Search Results 121-130 of 17086 for activated charcoal

1. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

2. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... active Crohn's disease (CD) in ...

3. Low blood oxygen (hypoxemia) Causes - Mayo Clinic

   Trouble with oxygen getting into the bloodstream and the waste gas carbon dioxide getting out. An issue with how blood flows in the heart. Changes in the ...

4. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to ...

5. Exercise and chronic disease: Get the facts - Mayo Clinic

   Even small amounts of physical activity can help. Being active for short periods during the day can add up to health benefits. For example, try walking briskly ...

6. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

   A history or evidence of human immunodeficiency virus (HIV) on screening or active hepatitis C virus (HCV), active hepatitis B virus (HBV) or active COVID-19 ...

7. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   ... active ulcerative colitis (UC). In addition, the safety profile of golimumab, in pediatric participants with moderately to severely active UC will be assessed.

8. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative ...

9. Mayo Clinic Minute: Fireworks and grilling safety reminders

   "Never operate a grill ― whether it's propane or charcoal ― inside or in poorly ventilated spaces." Ready to grill? Before you light that match, consider ...

10. Shortness of breath Causes - Mayo Clinic

    The heart and lungs help move oxygen to your body and get rid of carbon dioxide. ... New shortness of breath that starts after not being active for a long time.